Legal Opinion
Moss v. Wyeth Inc.
District Court, D. Connecticut
Decided May 24, 2012No. 3:04cv1511 (SRU)PublishedCited by 23 opinions
1Opinion of the Court
MEMORANDUM OF DECISION
STEFAN R. UNDERHILL, District Judge.
Defendants Wyeth, Inc. and Wyeth Pharmaceuticals, Inc. (collectively “Wyeth”) have argued that Connecticut “does not recognize strict liability claims for design defects in prescription drugs” under the Connecticut Product Liability Act (“CPLA”). See Wyeth’s Bench Br. Regarding Design Defect Claims Under Connecticut Law (doc. #295), at 1. That assertion is based on comment k of section 402A of the Restatement (Second) of Torts, which the Connecticut Supreme Court has adopted in principle, but has not yet fully defined in scope and…
2Cases cited36 opinions
- Feldman v. Lederle LaboratoriesSupreme Court of New Jersey · 1984
- Miller v. United Technologies Corp.Supreme Court of Connecticut · 1995
- Brown v. Superior CourtCalifornia Supreme Court · 1988
- General Motors Corp. v. SanchezTexas Supreme Court · 1999
- Judith Brochu and Emmanuel T. Brochu v. Ortho Pharmaceutical CorporationCourt of Appeals for the First Circuit · 1981
31 more not listed; retrieve them via the Exa API.
3Cited by23 opinions
- Lance v. WyethSupreme Court of Pennsylvania · 2014
- McConologue v. Smith & Nephew, Inc.District Court, D. Connecticut · 2014
- Fraser v. Wyeth, Inc.District Court, D. Connecticut · 2014
- Christiansen v. Wright Medical Technology Inc.District Court, N.D. Georgia · 2016
- Bourke v. Man Engines & Components, Inc.District Court, D. Connecticut · 2018
18 more not listed; retrieve them via the Exa API.